Stocktoria

Polaryx Therapeutics, Inc. PLYX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2026-02-02 · LEI

Polaryx Therapeutics, Inc. statistics & valuation

Market cap$113.6M
P / B24.9×
Return on equity-196.8%
Return on capital-171.3%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20242025
Operating margin (%)
20242025
Return on equity (%)
-644.20% -196.80% 20242025
Shares outstanding
41.2M 47.3M 20242025
Net debt ($)
20242025
Share buybacks ($)
20242025
Return on assets (%)
-607.00% -173.80% 20242025
Free cash flow margin (%)
20242025
Debt / equity (×)
20242025
EPS ($)
-$0.89 -$0.20 20242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024
Return on assets-173.8%-607.0%
Return on equity-196.8%-644.2%
Current ratio8.5517.30

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.